Showing 271-280 of 2157 results for "".
The Future of Beauty is Stacked, Preventive, and Driven by Technology
https://modernaesthetics.com/ma-issues-index/jan-feb-2026-issue/the-future-of-beauty-is-stacked-preventive-and-driven-by-technology/54430/Legalities of Injecting PDGF: Off-Label or Out-of-Bounds?
https://modernaesthetics.com/topics/regenerative-medicine/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/37871/Addressing Visible Signs of Aging and Skin Barrier Damage
https://modernaesthetics.com/ma-supplements/2025-jan-feb-supplement2/addressing-visible-signs-of-aging-and-skin-barrier-damage-1/35429/In Focus: Beauty Trends
https://modernaesthetics.com/topics/skincare/in-focus-beauty-trends/35245/Revision Skincare’s Dermal-Epidermal Junction (D-E-J) Daily Boosting Serum
https://modernaesthetics.com/topics/skincare/revision-skincares-dermal-epidermal-junction-d-e-j-daily-boosting-serum/35219/Buying Devices: Look Before You Leap
https://modernaesthetics.com/topics/practice-development/buying-devices-look-before-you-leap-part-2-dollars-and-good-sense/35217/Part 2: Dollars and Good SenseMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://beta.modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromPhyto A+ Brightening Treatment for Skin Brightening, Texture, and Clarity, Suitable for Sensitive Skin
https://modernaesthetics.com/ma-supplements/2022-jan-feb-insert/phyto-a-brightening-treatment-for-skin-brightening-texture-and-clarity-suitable-for-sensitive-skin/35139/MATV News: ASPS Stats, Upneeq Eyedrops for Ptosis; Allergan Acquires Soliton; The Beauty Health Company
https://beta.modernaesthetics.com/series/matv-news/matv-news-asps-stats-upneeq-eyedrops-for-ptosis-allergan-acquires-soliton-the-beauty-health-company/33633/Annual statistics from the American Society of Plastic Surgeons predict an increased demand for cosmetic plastic surgery and non-surgical procedures and Wendy Lee, MD discusses the role for RVL’s Upneeq, a non-surgical option for ptosis, in aesthetic practices. Plus, Allergan Aesthetics acquires SolMajor Mask Mistakes to Avoid Before and After Facial Cosmetic Surgery
https://modernaesthetics.com/topics/surgical/major-mask-mistakes-to-avoid-before-and-after-facial-cosmetic-surgery/33574/Face coverings are the new-normal and likely will be until there is a vaccine for COVID-19, but mask faux pas such as not disinfecting or discarding your dirty ones can affect your facial cosmetic surgery results, explains Joe Niamtu III, DMD, a cosmetic facial surgeon in Midlothian, VA. For more of